Isofol Medical AB (ISOFOL) Stock Overview

Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.